Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck says Zontivity approved for reduction of thrombotic cardiovascular events
The Fly on the Wall
Wednesday, May 21, 2014 - 11:16am
tags:
Merck, thrombotic cardiovascular events, Zontivity, FDA
Takeda’s Bowel Disease Drug Approved by U.S. Regulators
Bloomberg
Wednesday, May 21, 2014 - 10:26am
tags:
Takeda, FDA, Entyvio, vedolizumab, ulcerative colitis, Crohn's Disease
Valeant’s Pursuit of Allergan: Go Big or Go Home
Motley Fool
Wednesday, May 21, 2014 - 10:18am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Vertex: A Company-Defining Event Offers A Buying Opportunity
Seeking Alpha
Wednesday, May 21, 2014 - 10:16am
tags:
Vertex Pharmaceuticals, Kalydeco
Baxter provides U.S. regulatory update on HyQvia
The Fly on the Wall
Wednesday, May 21, 2014 - 10:13am
tags:
Baxter International, HyQvia, primary immunodeficiency, Halozyme
A New Kind of Free Speech: Drug Reps' Pitches to Doctors
The New Yorker
Wednesday, May 21, 2014 - 10:08am
tags:
free speech, off-label, physicians, drug reps
AstraZeneca Gets Woodford Backing of Pfizer Bid Rejection
Bloomberg
Wednesday, May 21, 2014 - 9:02am
tags:
Pfizer, M&A, AstraZeneca
Can AstraZeneca Live Up To CEO's Growth Plans? A Look At Its Pipeline
Forbes
Wednesday, May 21, 2014 - 8:52am
tags:
AstraZeneca, Pascal Soriot, pipeline
The Biggest Biotech Wins of the Week
Motley Fool
Wednesday, May 21, 2014 - 8:50am
tags:
Halozyme, Eli Lilly, Isis Pharmaceuticals
[video] Could Pfizer Turn Hostile Towards AstraZeneca?
Bloomberg
Wednesday, May 21, 2014 - 8:27am
tags:
Pfizer, AstraZeneca, M&A
Takeda Denies Hiding Diabetes Drug Risks in Nevada Trial
Bloomberg
Tuesday, May 20, 2014 - 5:38pm
tags:
Takeda, diabetes, Actos, bladder cancer
Sun Pharma response to import ban inadequate - FDA
Yahoo/Reuters
Tuesday, May 20, 2014 - 4:20pm
tags:
Sun Pharma, India, FDA, drug importation
AstraZeneca says 'absolutely clear' that Pfizer offer final, can't be raised
The Fly on the Wall
Tuesday, May 20, 2014 - 4:05pm
tags:
AstraZeneca, Pfizer, M&A
SEC cries insider trading in GTx's halted cancer trial
Fierce Pharma
Tuesday, May 20, 2014 - 4:04pm
tags:
SEC, GTx, Capesaris
Side effect analysis suggests Gilead's hep C wonder Sovaldi is safer than rivals, too
Fierce Pharma
Tuesday, May 20, 2014 - 11:46am
tags:
Sovaldi, side effects, hepatitis C, Gilead Sciences
AstraZeneca Rebuffs Pfizer's "Final" Offer; Now What?
Motley Fool
Tuesday, May 20, 2014 - 11:44am
tags:
AstraZeneca, Pfizer, M&A
Ophthotech deal with Novartis leaves Fovista well-positioned, says Stifel
The Fly on the Wall
Tuesday, May 20, 2014 - 11:24am
tags:
Ophthotech, Fovista, Novartis, wet age-related macular degeneration, wet-AMD
Stemline's SL-401 significantly decreased the viability of malignant cells
The Fly on the Wall
Tuesday, May 20, 2014 - 11:23am
tags:
Stemline Therapeutics, SL-401, Multiple Myeloma
Why Dendreon (DNDN) Stock Is Surging Today
TheStreet.com
Tuesday, May 20, 2014 - 11:22am
tags:
Dendreon, prostate cancer, Provenge
Teva launching 3 drugs in 2014 with combined peak sales of $1 bln
Yahoo/Reuters
Tuesday, May 20, 2014 - 11:19am
tags:
Teva Pharmaceuticals, Zecuity

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.